相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumor necrosis factor primes and metal particles activate the NLRP3 inflammasome in human primary macrophages
Eemeli Jamsen et al.
ACTA BIOMATERIALIA (2020)
Long Noncoding RNA H19 Contributes to Cholangiocyte Proliferation and Cholestatic Liver Fibrosis in Biliary Atresia
Yongtao Xiao et al.
HEPATOLOGY (2019)
Sphingosine 1-Phosphate Receptor Blockade Affects Pro-Inflammatory Bone Marrow-Derived Macrophages and Relieves Mouse Fatty Liver Injury
Jingjing Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Regulation of the metabolism of apolipoprotein M and sphingosine 1-phosphate by hepatic PPARγ activity
Makoto Kurano et al.
BIOCHEMICAL JOURNAL (2018)
Sphingosine-1-phosphate receptors and innate immunity
Arielle M. Bryan et al.
CELLULAR MICROBIOLOGY (2018)
Sphingosine-1-phosphate receptor 1 mediates elevated IL-6 signaling to promote chronic inflammation and multitissue damage in sickle cell disease
Shushan Zhao et al.
FASEB JOURNAL (2018)
Inflammasome biology, molecular pathology and therapeutic implications
Fawaz Awad et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Deoxycholic Acid-Mediated Sphingosine-1-Phosphate Receptor 2 Signaling Exacerbates DSS-Induced Colitis through Promoting Cathepsin B Release
Shengnan Zhao et al.
Journal of Immunology Research (2018)
Sphingosine 1-Phosphate (S1P)/S1P Receptor2/3 Axis Promotes Inflammatory M1 Polarization of Bone Marrow-Derived Monocyte/Macrophage via G(α)i/o/PI3K/JNK Pathway
Jingjing Yang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
FXR Inhibits Endoplasmic Reticulum Stress-Induced NLRP3 Inflammasome in Hepatocytes and Ameliorates Liver Injury
Chang Yeob Han et al.
CELL REPORTS (2018)
Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases
Congfei Xu et al.
NATURE COMMUNICATIONS (2018)
Targeting CCl4-Induced Liver Fibrosis by RNA Interference-Mediated Inhibition of Cyclin E1 in Mice
Joerg-Martin Bangen et al.
HEPATOLOGY (2017)
The Role of Sphingosine 1-Phosphate Receptor 2 in Bile-Acid-Induced Cholangiocyte Proliferation and Cholestasis-Induced Liver Injury in Mice
Yongqing Wang et al.
HEPATOLOGY (2017)
TNF regulates transcription of NLRP3 inflammasome components and inflammatory molecules in cryopyrinopathies
Matthew D. McGeough et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β
Benjamin Weichand et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production
Xin Yu et al.
JOURNAL OF HEPATOLOGY (2017)
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
Auvro R. Mridha et al.
JOURNAL OF HEPATOLOGY (2017)
Sphingosine-1-phosphate receptor therapies: Advances in clinical trials for CNS-related diseases
Sinead O'Sullivan et al.
NEUROPHARMACOLOGY (2017)
Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis
Burhan Z. Chaudhry et al.
NEUROTHERAPEUTICS (2017)
Bile Acid-Mediated Sphingosine-1-Phosphate Receptor 2 Signaling Promotes Neuroinflammation during Hepatic Encephalopathy in Mice
Matthew McMillin et al.
Frontiers in Cellular Neuroscience (2017)
Modulation of sphingosine-1-phosphate in inflammatory bowel disease
Laurent Peyrin-Biroulet et al.
AUTOIMMUNITY REVIEWS (2017)
CdSe/ZnS quantum dots induce hepatocyte pyroptosis and liver inflammation via NLRP3 inflammasome activation
Yonghui Lu et al.
BIOMATERIALS (2016)
Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies
Cynthia Ju et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Herbert Tilg et al.
HEPATOLOGY (2016)
Dihydroartemisinin Restricts Hepatic Stellate Cell Contraction via an FXR-S1PR2-dependent Mechanism
Wenxuan Xu et al.
IUBMB LIFE (2016)
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies
Giovanni Musso et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate
Antonio Gomez-Munoz et al.
PROGRESS IN LIPID RESEARCH (2016)
Mechanism and Regulation of NLRP3 Inflammasome Activation
Yuan He et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Sphingosine kinase-1, S1P transporter spinster homolog 2 and S1P2 mRNA expressions are increased in liver with advanced fibrosis in human
Masaya Sato et al.
SCIENTIFIC REPORTS (2016)
Conjugated Bile Acid-Activated S1P Receptor 2 Is a Key Regulator of Sphingosine Kinase 2 and Hepatic Gene Expression
Masayuki Nagahashi et al.
HEPATOLOGY (2015)
Exosome Adherence and Internalization by Hepatic Stellate Cells Triggers Sphingosine 1-Phosphate-dependent Migration
Ruisi Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Endocannabinoid System Contributes to Liver Injury and Inflammation by Activation of Bone Marrow-Derived Monocytes/Macrophages in a CB1-Dependent Manner
Ping Mai et al.
JOURNAL OF IMMUNOLOGY (2015)
Sources, metabolism, and regulation of circulating sphingosine-1-phosphate
Monika Ksiazek et al.
JOURNAL OF LIPID RESEARCH (2015)
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Rebecca C. Coll et al.
NATURE MEDICINE (2015)
Knocking down disease: a progress report on siRNA therapeutics
Anders Wittrup et al.
NATURE REVIEWS GENETICS (2015)
Sphingosine 1-Phosphate Receptor 2 and 3 Mediate Bone Marrow-Derived Monocyte/Macrophage Motility in Cholestatic Liver Injury in Mice
Le Yang et al.
SCIENTIFIC REPORTS (2015)
NLRP3 Inflammasome Activation Results in Hepatocyte Pyroptosis, Liver Inflammation, and Fibrosis in Mice
Alexander Wree et al.
HEPATOLOGY (2014)
NLRP3 inflammasome activation is required for fibrosis development in NAFLD
Alexander Wree et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis is involved in liver fibrosis-associated angiogenesis
Le Yang et al.
JOURNAL OF HEPATOLOGY (2013)
Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes
Tony Jourdan et al.
NATURE MEDICINE (2013)
Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond
Gregory T. Kunkel et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
15-deoxy-Δ12,14-prostaglandin J2 reduces recruitment of bone marrow-derived monocyte/macrophages in chronic liver injury in mice
Zhen Han et al.
HEPATOLOGY (2012)
Antagonism of sphingosine 1-phosphate receptor 2 causes a selective reduction of portal vein pressure in bile duct-ligated rodents
Yuko Kageyama et al.
HEPATOLOGY (2012)
Inflammasomes in liver diseases
Gyongyi Szabo et al.
JOURNAL OF HEPATOLOGY (2012)
Defining GM-CSF- and Macrophage-CSF Dependent Macrophage Responses by In Vitro Models
Derek C. Lacey et al.
JOURNAL OF IMMUNOLOGY (2012)
Sphingosine-1-Phosphate Receptor-2 Function in Myeloid Cells Regulates Vascular Inflammation and Atherosclerosis
Athanasia Skoura et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Glucan particles for selective delivery of siRNA to phagocytic cells in mice
Gregory J. Tesz et al.
BIOCHEMICAL JOURNAL (2011)
Sphingosine 1-phosphate (S1P)/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility
Changyong Li et al.
JOURNAL OF HEPATOLOGY (2011)
Bile acids regulate hepatic gluconeogenic genes and farnesoid X receptor via Gαi-protein-coupled receptors and the AKT pathway
Risheng Cao et al.
JOURNAL OF LIPID RESEARCH (2010)
An update on sphingosine-1-phosphate and other sphingolipid mediators
Henrik Fyrst et al.
NATURE CHEMICAL BIOLOGY (2010)
Sphingosine 1-phosphate regulates regeneration and fibrosis after liver injury via sphingosine 1-phosphate receptor 2
Hitoshi Ikeda et al.
JOURNAL OF LIPID RESEARCH (2009)
Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages
Jeniter E. Hughes et al.
CIRCULATION RESEARCH (2008)
"Inside-Out" Signaling of Sphingosine-1-Phosphate: Therapeutic Targets
K. Takabe et al.
PHARMACOLOGICAL REVIEWS (2008)
分享论文
